|
|
Copyright © LARVOL 2024. All rights reserved. Visit ASH 2019: Updated Progression-Free Survival (PFS) and Overall Survival (https://clin.larvol.com/abstract-detail/ASH%202019/36087288)
|
Top Keywords: survival, 2019, ash, pfs and, and overall, free survival, overall survival, pfs, progression, overall, updated, trials, influencers, population, conferences, all rights reserved, rights reserved, all rights, copyright, rights, beta, terms of service, of service, key, o, terms of, phase 2 study, results from the, in patients with, relapsed refractory, figures for, 2019 updated, for ash, with relapsed, and dexamethasone, o 12, Theres a total of 64 keywords.
Inbound and Outbound LinksThere is currently no known inbound links. There is currently no known outbound links. |
Statistics
We first found this page on 2023-03-19 00:00:14 +0000. It was last re-indexed on 2024-12-27 06:39:16 +0000 and with a fetch interval of 90 days it will be fetched again in 55 days on 2025-03-26 or soon thereafter.
Last fetch returned code 200, OK, the current page state is ACTIVE.
Traffic Data for clin.larvol.com
Traffic data is only available for sites with a CashRank of $15 or better, an Alexa rank better than 100,000 or PageRank of 2 or more.If you are the owner of /clin.larvol.com and you want to remove this page from the search results, just use robots.txt
Similar Sites
ASH 2019: Updated Progression-Free Survival (PFS) and Overall Survival
Copyright © LARVOL 2024. All rights reserved.
https://clin.larvol.com/abstract-detail/ASH%202019/36087288
- Details - Similar
About: Accounting and Business Expert - Bryan Parker
Accounting Business Expert Witness Bryan Parker qualified experienced CPA CFA provides financial analysis and evaluation litigation reports.
https://bryanparkercpa.com/about/
- Details - Similar
ipafricept (OMP-54F28) / Mereo Biopharma
News for ipafricept (OMP-54F28) / Mereo Biopharma
https://delta.larvol.com/Products/?ProductId=2d934168-eaf0-4319-994e-a4cd0009f26e
- Details - Similar
tusamitamab ravtansine (SAR408701) / Sanofi, Innovent Biologics, AbbVi
News for tusamitamab ravtansine (SAR408701) / Sanofi, Innovent Biologics, AbbVie
https://delta.larvol.com/Products/?ProductId=40ecf5df-fb10-4c8e-9f87-584fbc0b3715
- Details - Similar
More sites similar to ASH 2019: Updated Progression-Free Survival (PFS) and Overall Survival...
Find Another Website
Sponsored Results
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less